Transforming epidemiology for 21st century medicine and public health

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 4, 2013, Pages 508-516

  Khoury, Muin J ^a,e   Lam, Tram Kim ^a   Ioannidis, John P A ^f   Hartge, Patricia ^b   Spitz, Margaret R ^g   Buring, Julie E ^h   Chanock, Stephen J ^b   Croyle, Robert T ^a   Goddard, Katrina A ^l   Ginsburg, Geoffrey S ^m   Herceg, Zdenko ⁿ   Hiatt, Robert A ^o   Hoover, Robert N ^b   Hunter, David J ^j   Kramer, Barnet S ^c   Lauer, Michael S ^d   Meyerhardt, Jeffrey A ⁱ   Olopade, Olufunmilayo I ^p   Palmer, Julie R ^k   Sellers, Thomas A ^q   Seminara, Daniela ^a   Ransohoff, David F ^r   Rebbeck, Timothy R ^s   Tourassi, Georgia ^t   Winn, Deborah M ^a   Zauber, Ann ^u   Schully, Sheri D ^a   more..

^a Cancer Control and Population Sciences   (United States)

^b Div of Cancer Epidemiol and Genet   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ DANA FARBER CANCER INSTITUTE   (United States)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k BOSTON UNIVERSITY   (United States)

^l CENTER FOR HEALTH RESEARCH   (United States)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^q H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^r UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF PENNSYLVANIA   (United States)

^t OAK RIDGE NATIONAL LABORATORY   (United States)

^u MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; HEALTH CARE POLICY; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL SOCIETY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; REPRODUCIBILITY; TRANSLATIONAL RESEARCH;

BIOMEDICAL RESEARCH; EPIDEMIOLOGIC STUDIES; GUIDELINES AS TOPIC; HISTORY, 21ST CENTURY; HUMANS; MEDICAL ONCOLOGY; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PUBLIC HEALTH; UNITED STATES;

EID: 84876517223     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0146     Document Type: Article

References (51)

1. Koplan JP, Thacker SB, Lezin NA. Epidemiology in the 21st century: calculation, communication, and intervention. Am J Public Health 1999;89:1153-5. (Pubitemid 29359564)
2. Greenwald P, Dunn BK. Landmarks in the history of cancer epidemiology. Cancer Res 2009;69:2151-62.
3. Lauer MS. Time for a creative transformation of epidemiology in the United States. JAMA 2012;308:1804-5.
4. Khoury MJ, Gwinn M, Ioannidis JP. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 2010;172:517-24.
5. Lam TK, Spitz M, Schully SD, Khoury MJ. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev 2013;22:181-8
6. Khoury MJ, Freedman AN, Gillanders EM, Harvey CE, Kaefer C, Reid BC, et al. Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute. Cancer Epidemiol Biomarkers Prev 2012;21:999-1001.
7. National Cancer Institute. Cancer Epidemiology Matters Blog. [cited March 9, 2013]. Available from: (http://blog-epi.grants.cancer.gov/).
8. Ioannidis JP, Schully SD, Lam TK, Khoury MJ. Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev 2013;22:3-10.
9. Verma M, Khoury MJ, Ioannidis JP. Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev 2013;22:189-200.
10. Ransohoff DF. Cultivating cohort studies for observational translational research. Cancer Epidemiol Biomarkers Prev 2013; 22:481-4.
11. Lam TK, Schully SD, Rogers SD, Benkeser R, Reid BB, Khoury MJ. Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints. Cancer Epidemiol Biomarkers Prev 2013;22:496-500.
12. National Cancer Institute Workshop. Trends in 21st century epidemiology: from scientific discoveries to population health impact; 2012 [cited 2012 Dec 12-13]. Available from: (http://epi.grants.cancer.gov/workshops/century-trends/) .
13. Best A, Hiatt RA, Norman CD. Knowledge integration: conceptualizing communications in cancer control systems. Patient Educ Couns 2008;71:319-27.
14. Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard- Barbash R, Bhatia S, et al. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst 2013;105:85-94.
15. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st -century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-50.
16. Hall KL, Feng AX, Moser RP, Stokols D, Taylor BK. Moving the science of team science forward: collaboration and creativity. Am J Prev Med 2008;35:S243-9. (Pubitemid 351934616)
17. Hiatt RA. Epidemiology: key to translational, team, and transdisciplinary science. Ann Epidemiol 2008;18:859-61.
18. Lynch S, Rebbeck TR. Bridging the gap between biological, individual, and macro-environmental factors in cancer: a multi-level approach. Cancer Epidemiol Biomarkers Prev 2013;22:485-95.
19. Zoghbi HY. The basics of translation. Science 2013;339:250.
20. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
21. Hunter DJ. Lessons from genome-wide association studies for epidemiology. Epidemiology 2012;23:363-7.
22. Tenopir C, Allard S, Douglass K, Aydinoglu AU, Wu L, Read E, et al. Data sharing by scientists: practices and perceptions. PLoS ONE 2011;6:e21101.
23. Guttmacher AE, Nabel EG, Collins FS. Why data-sharing policies matter. Proc Natl Acad Sci U S A 2009;106:16894.
24. Birney E, Hudson TJ, Green ED, Gunter C, Eddy S, Rogers J, et al. Prepublication data sharing. Nature 2009;461:168-70.
25. Ioannidis JP, Khoury MJ. Improving validation practices in "omics" research. Science 2011;334:1230-2.
26. Alsheikh-Ali AA, Qureshi W, Al-Mallah MH, Ioannidis JP. Public availability of published research data in high-impact journals. PLoS ONE 2011;6:e24357.
27. Kaye J. The tension between data sharing and the protection of privacy in genomics research. Annu Rev Genomics Hum Genet 2012;13: 415-31.
28. Ioannidis JP. The importance of potential studies that have not existed and registration of observational data sets. JAMA 2012;308:575-6.
29. Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'Heureux F, et al. Quality,quantity and harmony: theDataSHaPERapproach to integrating data across bioclinical studies. Int J Epidemiol 2010;39:1383-93.
30. Harris JR, Burton P, Knoppers BM, Lindpaintner K, Bledsoe M, Brookes AJ, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet 2012;20:1105-11.
31. Manolio TA, Weis BK, Cowie CC, Hoover RN, Hudson K, Kramer BS, et al. New models for large prospective studies: is there a better way? Am J Epidemiol 2012;175:859-66.
32. National Cancer Institute. Epidemiology and Genomics Research Program. Cohort Consortium. Available from: http://epi.grants. cancer.gov/Consortia/ cohort.html.
33. Collins R. What makes UK Biobank special? Lancet 2012;379: 1173-4.
34. Cancer Genome Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.
35. Cancer Genome Atlas Research Network.Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489: 519-25.
36. Haring R, Wallaschofski H. Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS 2012;16: 231-4.
37. Paules RS, Aubrecht J, Corvi R, Garthoff B, Kleinjans JC. Moving forward in human cancer risk assessment. Environ Health Perspect 2011;119:739-43.
38. Rappaport SM, Smith MT. Epidemiology. environment and disease risks. Science 2010;330:460-1.
39. Mervis J. U.S. science policy. Agencies rally to tackle big data. Science 2012;336:22.
40. Birney E. The making of ENCODE: lessons for big-data projects. Nature 2012;489:49-51.
41. Pechette JM. Transforming health care through cloud computing. Health Care Law Mon 2012;2012:2-12.
42. National Institute of Standards and Technology Workshop: cloud computing and big data; 2013 [accessed March 9, 2013]. Available from: http://www.nist.gov/itl/math/cloud-112912.cfm.
43. Galea S, Riddle M, Kaplan GA. Causal thinking and complex system approaches in epidemiology. Int J Epidemiol 2010;39: 97-106.
44. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 2008;3:e3081.
45. Armenian HK. Epidemiology: a problem-solving journey. Am J Epidemiol 2009;169:127-31.
46. Kuller LH. Point: is there a future for innovative epidemiology? Am J Epidemiol 2013;177:279-80.
47. Ness RB. Tools for innovative thinking in epidemiology. Am J Epidemiol 2012;175:733-8.
48. Spitz MR, Caporaso NE, Sellers TA. Integrative cancer epidemiology- the next generation. Cancer Discov 2012;2:1087-90.
49. Arbyn M, Andersson K, Bergeron C, Bogers JP, von Knebel-Doebertitz M, Dillner J. Cervical cytology biobanks as a resource for molecular epidemiology. Methods Mol Biol 2011;675:279-98.
50. Fenstermacher DA, Wenham RM, Rollison DE, Dalton WS. Implementing personalized medicine in a cancer center. Cancer J 2011;17: 528-36.
51. Lieu TA, Hinrichsen VL, Moreira A, Platt R. Collaborations in population- based health research: the 17th annual HMO Research Network Conference, March 23-25, 2011, Boston, Massachusetts, USA. Clin Med Res 2011;9:137-40.